Carregant...
Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy
Tumor lysis syndrome (TLS) is a potentially life-threatening complication of cancer therapy characterized by two or more of the following laboratory abnormalities: hyperuricemia, hyperkalemia, hypocalcemia, and hyperphosphatemia, with resultant end-organ damage, eg, renal failure, seizures, or cardi...
Guardat en:
| Publicat a: | Core Evid |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4298251/ https://ncbi.nlm.nih.gov/pubmed/25610345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S54995 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|